Completion of Diagnostic Services sale

Johnson Matthey PLC

02 October 2023

 

2^nd October 2023

Johnson Matthey Plc

(the Company)

Johnson Matthey announces completion of Diagnostic Services (also known as Tracerco) sale

Further to the announcement on 3^rd May 2023, Johnson Matthey Plc (JM) is pleased to announce that it has completed the sale of its Diagnostic Services business on 29^th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

ENDS

Enquiries:
Investor Relations Martin Dunwoodie Louise Curran Carla Fabiano	Director of Investor Relations Senior Investor Relations Manager Senior Investor Relations Manager	020 7269 8241 020 7269 8235 020 7269 8004
Media Harry Cameron	Teneo	020 7353 4200

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

END